AllerNaze

Last reviewed on RxList: 5/25/2021
AllerNaze Side Effects Center

What Is AllerNaze?

AllerNaze (triamcinolone acetonide) Nasal Spray is a corticosteroid used to treat the nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 12 years of age or older. The brand name AllerNaze Nasal Spray is discontinued, but generic versions may be available.

What Are Side Effects of AllerNaze?

Common side effects of AllerNaze (triamcinolone acetonide) Nasal Spray include:

  • application site reaction (nasal burning and stinging
  • runny or stuffy nose
  • menstrual pain, and
  • allergic reactions

Dosage for AllerNaze

The recommended starting dose of AllerNaze for most patients is 200 mcg per day given as 2 sprays (approximately 50 mcg/spray) in each nostril once a day.

What Drugs, Substances, or Supplements Interact with AllerNaze?

AllerNaze may interact with other drugs. Tell your doctor all medications and supplements you use.

AllerNaze During Pregnancy or Breastfeeding

During pregnancy, AllerNaze should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our AllerNaze (triamcinolone acetonide) Nasal Spray Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Could I Be Allergic? Discover Your Allergy Triggers See Slideshow
AllerNaze Consumer Information

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • worsening of your skin condition;
  • redness, warmth, swelling, oozing, or severe irritation of any treated skin;
  • blurred vision, tunnel vision, eye pain, or seeing halos around lights;
  • high blood sugar--increased thirst, increased urination, dry mouth, fruity breath odor; or
  • possible signs of absorbing this medicine through your skin or gums--weight gain (especially in your face or your upper back and torso), slow wound healing, thinning or discolored skin, increased body hair, muscle weakness, nausea, diarrhea, tiredness, mood changes, menstrual changes, sexual changes.

Children can absorb larger amounts of this medicine through the skin and may be more likely to have side effects such as growth delay, headaches, or pain behind the eyes. A baby using this medicine may have a bulging soft spot (the top of the head where the skull hasn't yet grown together).

Common side effects may include:

  • burning, itching, dryness, or other irritation of treated skin;
  • redness or crusting around your hair follicles;
  • redness or itching around your mouth;
  • allergic skin reaction;
  • stretch marks;
  • acne, increased body hair growth;
  • thinning skin or discoloration; or
  • white or "pruned" appearance of the skin (caused by covering treated skin with a tight bandage or other covering).

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for AllerNaze (Triamcinolone Acetonide Nasal Spray)

QUESTION

Allergies can best be described as: See Answer
AllerNaze Professional Information

SIDE EFFECTS

In adequate, well-controlled and uncontrolled studies, 1187 patients have received triamcinolone acetonide solution. The adverse reactions summarized below, are based upon seven placebo controlled clinical trials of 2-6 weeks duration in 847 patients with seasonal or perennial allergic rhinitis (504 patients received 200 mcg or 400 mcg per day of triamcinolone acetonide solution and 343 patients received vehicle placebo). Adverse events reported by 2% or more of patients (regardless of relationship to treatment) who received triamcinolone acetonide solution 200 or 400 mcg once daily and that were more common with triamcinolone acetonide solution than with placebo are displayed in the table below. Overall, the incidence and nature of adverse events with triamcinolone acetonide solution 400 mcg was comparable to that seen with triamcinolone acetonide solution 200 mcg and with vehicle placebo.

ADVERSE EVENTS REPORTED AT A FREQUENCY OF 2% OR GREATER AND MORE COMMON AMONG PATIENTS TREATED WITH triamcinolone acetonide solution THAN PLACEBO REGARDLESS OF RELATIONSHIP TO TREATMENT

ADVERSE EVENTS 200 mcg of
triamcinolone
acetonide
once daily
n = 204
400 mcg of
triamcinolone
acetonide
once daily
n = 300
Combined
(200 and 400 mcg)
use of triamcinolone
acetonide
n = 504
Vehicle
Placebo
n = 343
BODY AS A WHOLE
Headache 51.0% 44.3% 47.0% 41.1%
Back Pain 7.8% 4.7% 6.0% 3.5%
RESPIRATORY SYSTEM
Pharyngitis 13.7% 10.3% 11.7% 7.9%
Asthma 5.4% 4.3% 4.8% 2.9%
Cough Increased 2.0% 2.7% 2.4% 2.3%
DIGESTIVE SYSTEM
Dyspepsia 4.9% 2.7% 3.6% 2.0%
Nausea 2.0% 3.0% 2.6% 0.6%
Vomiting 1.5% 2.7% 2.2% 1.5%
SPECIAL SENSES
Taste Perversion 7.8% 5.0% 6.2% 2.9%
Conjunctivitis 4.4% 1.3% 2.6% 1.5%
MUSCULOSKELETAL SYSTEM
Myalgia 2.5% 3.3% 3.0% 2.6%

Adverse events reported by 2% or more of patients who received triamcinolone acetonide solution 200 or 400 mcg once daily and that were more common with placebo than with triamcinolone acetonide solution included: application site reaction (e.g. transient nasal burning and stinging), rhinitis, dysmenorrhea, pain (unspecified) and allergic reaction.

The adverse effects related to the irritation of nasal mucous membranes (i.e. application site reaction) did not usually interfere with treatment. In the controlled and uncontrolled studies, approximately 0.3% of patients discontinued because of irritation of nasal mucous membranes.

Read the entire FDA prescribing information for AllerNaze (Triamcinolone Acetonide Nasal Spray)

© AllerNaze Patient Information is supplied by Cerner Multum, Inc. and AllerNaze Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors